ES545052A0 - Un procedimiento para producir un derivado de un polipeptido de interferon-gamma-humano - Google Patents

Un procedimiento para producir un derivado de un polipeptido de interferon-gamma-humano

Info

Publication number
ES545052A0
ES545052A0 ES545052A ES545052A ES545052A0 ES 545052 A0 ES545052 A0 ES 545052A0 ES 545052 A ES545052 A ES 545052A ES 545052 A ES545052 A ES 545052A ES 545052 A0 ES545052 A0 ES 545052A0
Authority
ES
Spain
Prior art keywords
gamma
derivative
interferon
procedure
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES545052A
Other languages
English (en)
Other versions
ES8609484A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15350817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES545052(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of ES545052A0 publication Critical patent/ES545052A0/es
Publication of ES8609484A1 publication Critical patent/ES8609484A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES545052A 1984-07-11 1985-07-10 Un procedimiento para producir un derivado de un polipeptido de interferon-gamma-humano Expired ES8609484A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14395084A JPS6124599A (ja) 1984-07-11 1984-07-11 新規ヒトインタ−フエロン−ｒポリペプチド誘導体

Publications (2)

Publication Number Publication Date
ES545052A0 true ES545052A0 (es) 1986-09-01
ES8609484A1 ES8609484A1 (es) 1986-09-01

Family

ID=15350817

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545052A Expired ES8609484A1 (es) 1984-07-11 1985-07-10 Un procedimiento para producir un derivado de un polipeptido de interferon-gamma-humano

Country Status (11)

Country Link
US (1) US4898931A (es)
EP (1) EP0170917B1 (es)
JP (1) JPS6124599A (es)
AT (1) ATE63923T1 (es)
AU (1) AU586822B2 (es)
CA (1) CA1303529C (es)
DE (2) DE3582973D1 (es)
DK (1) DK164108C (es)
ES (1) ES8609484A1 (es)
IL (1) IL75738A (es)
NO (1) NO175487C (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334102D0 (en) * 1983-12-21 1984-02-01 Searle & Co Interferons with cysteine pattern
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
AT393690B (de) * 1987-10-08 1991-11-25 Hoffmann La Roche Homogene, rekombinante immun-interferonfragmente
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
DE4036856C1 (es) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
CN1900116A (zh) * 1995-01-26 2007-01-24 拜奥根Idec马萨诸塞公司 抗－LT－β－R抗体、含有该抗体的药用组合物及其制药应用
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2003513681A (ja) * 1999-11-12 2003-04-15 マキシゲン・ホールディングス・リミテッド インターフェロンガンマ・コンジュゲート
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
AU782635B2 (en) * 1999-11-12 2005-08-18 Maxygen Holdings Ltd. Interferon gamma conjugates
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US7524931B2 (en) 2002-07-03 2009-04-28 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
CA2609205A1 (en) * 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
EP1991679A2 (fr) * 2006-03-08 2008-11-19 Biomethodes Variants de l'interferon- gamma humain (ifngamma)
FR2898359B1 (fr) * 2006-03-08 2011-07-15 Biomethodes Variants ameliores de l'interferon-gamma humain (ifn gamma)
CA2712606A1 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
MX2021001165A (es) * 2018-07-30 2021-07-15 Univ Leland Stanford Junior Agonistas sesgados de interferon-gamma.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same
US4758656A (en) * 1983-12-26 1988-07-19 Kyowa Hakko Kogyo Co., Ltd. Novel human interferon-gamma polypeptide derivative
AU582574B2 (en) * 1984-04-19 1989-04-06 Hoechst Aktiengesellschaft The preparation of polypeptides having human gamma interferon activity
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof

Also Published As

Publication number Publication date
ATE63923T1 (de) 1991-06-15
EP0170917A1 (en) 1986-02-12
EP0170917B1 (en) 1991-05-29
DK314485D0 (da) 1985-07-10
DE3582973D1 (de) 1991-07-04
CA1303529C (en) 1992-06-16
NO852776L (no) 1986-01-13
NO175487C (no) 1994-10-19
DK164108B (da) 1992-05-11
NO175487B (no) 1994-07-11
AU4474985A (en) 1986-01-16
DK164108C (da) 1992-10-12
ES8609484A1 (es) 1986-09-01
IL75738A0 (en) 1985-11-29
AU586822B2 (en) 1989-07-27
JPS6124599A (ja) 1986-02-03
IL75738A (en) 1995-06-29
DE170917T1 (de) 1986-09-04
DK314485A (da) 1986-01-12
US4898931A (en) 1990-02-06

Similar Documents

Publication Publication Date Title
ES545052A0 (es) Un procedimiento para producir un derivado de un polipeptido de interferon-gamma-humano
NO780151L (no) Fremgangsmaate for fremstilling av fysiologisk aktive acylderivater av aminosyrer
IT8048102A0 (it) Procedimento di preparazione di un idrolisato di proteine purificato
IT8049654A0 (it) Procedimento per la preparazione di collageno biologicamente attivo ma cromolecolare e prodotto ottenuto
NO172389C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler
ES543686A0 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
ES552935A0 (es) Procedimiento para la produccion de d-l-amino acidos
SE503436C2 (sv) Pyroglutamidderivat
AR229931A1 (es) Procedimiento para producir interferon de fibroblasto humano esencialmente purificado como proteina homogenea
PL261087A1 (en) Method of obtaining novel derivatives of amino acids
MX14287A (es) Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos
MX161989A (es) Procedimiento para preparar metilester de alfa-l-aspartil-l-fenilalanina o clorhidrato del mismo
GB2001056B (en) -acetylene and -vinyl derivative of amino acids
IT8268431A0 (it) Plicazione terapeutica n vinblastin 23 il derivati di amminoacidi loro preparazione ed ap
IT1107454B (it) Derivati alfa-alogenometilici di amminoacidi e relativo procedimento di produzione
ES553632A0 (es) Procedimiento para preparar esteres de acidos 6-bromopiridin-2-il-fosforicos
IT1172237B (it) Derivati di amminoacidi particolarmente utili come medicammenti e procedimento per la loro preparazione
IT7951108A0 (it) Procedimento per la preparazione di cloridrati di amminoacidi e biclori drati di diamminoacidi
IT7850102A0 (it) Procedimento per la produzione di derivati di amminoacidi alfa-aceti lenici e prodotto ottenuto
GB2174298B (en) An improved process for increasing the sexual activity of birds and useful domestic mammals and for preparing spermatozoa suitable to their propagation
MX17291A (es) Derivados del acido glutamico y procedimiento para su preparacion.
DK489086A (da) Tetradecapeptider med mitogen aktivitet og fremgangsmaade til stimulering af vaeksten af macrophag-lignende celler
IT7969375A0 (it) N 23 vinblastinoil derivati di amminoacidi e di peptidi particolarmente utili come antitumorali e procedimento per la loro preparazione
AU491446B2 (en) Amino acid formulations for patients with liver disease and method of using same
IT1196167B (it) Procedimento per la preparazione di n-tiocarbossianidridi di amminoacidi

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601